Last reviewed · How we verify
NCT05973916
Comprehensive Intervention to Improve Environmental Disinfection
NA trial testing Comprehensive intervention in Hospital Acquired Condition in 1,400 participants. Currently enrolling.
2 February 2025
Quick facts
| Lead sponsor | Assaf-Harofeh Medical Center |
|---|---|
| Phase | NA |
| Status | Recruiting now |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | crossover |
| Masking | none |
| Primary purpose | prevention |
| Enrollment | 1,400 |
| Start date | 3 August 2023 |
| Primary completion | 2 February 2025 |
| Estimated completion | 3 August 2025 |
| Sites | 1 location across Israel |
Drugs / interventions tested
- Comprehensive intervention
Conditions studied
- Hospital Acquired Condition — all drugs for Hospital Acquired Condition →
Sponsor
Assaf-Harofeh Medical Center
Who can join
18 and older, any sex, with Hospital Acquired Condition. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
A comprehensive intervention to improve the level of cleaning and disinfection of patients' units, in order to reduce new acquisitions and environmental contamination by multidrug resistant organisms: a prospective controlled crossover trial, using VYV led lights and continuous air filtering of patients' rooms, coupled with establishment of a "patient's unit commando" cleaning team.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT05973916
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Comprehensive intervention
Trials testing the same drug.
- NCT04517981 — Cohort Study on the Outcome and Influencing Factors of Perinatal Depression · unknown
Other recruiting trials for Hospital Acquired Condition
Currently open trials in the same condition.
- NCT06359587 — Re-Purposing the Ordering of Routine Laboratory Tests in Hospitals in British Columbia · NA · recruiting
- NCT06326424 — Delirium Identification in Older Patients With Alzheimer's and Other Related Dementias In the Emergency Department · recruiting
- NCT06174844 — Assessment of the Humanisation of Care in Hospitals in Andalusia-Spain · recruiting
- NCT06089239 — Choosing Wisely: De-implementing Fall Prevention Alarms in Hospitals · NA · recruiting
- NCT05725928 — Assisted Ambulation to Improve Health Outcomes for Older Medical Inpatients · NA · recruiting
Other Assaf-Harofeh Medical Center trials
Trials by the same sponsor.
- NCT07334639 — Metabolic Changes Associated With Weight Gain After Treatment of Achalasia · not yet recruiting
- NCT07276334 — Same Day Discharge Vs. Hospitalization for Operative Fixation of Distal Radius Fractures · NA · enrolling by invitation
- NCT07231900 — Sodium Bicarbonate in Intra-dialytic Hypertension in Chronic Hemodialysis Patients · Phase 2, PHASE3 · not yet recruiting
- NCT07252180 — Comparing Two Different Methods of Ablation of Inlet Patches (APC vs RFA) · NA · active not recruiting
- NCT04664790 — Hyperbaric Oxygen Therapy Compared to Cognitive Training in FASD · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05973916 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Assaf-Harofeh Medical Center
- Last refreshed: 31 July 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05973916.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing